Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-14

Clinical Trial Update: Evaluate Safety and Explore Efficacy of FURESTEM-OA Kit Inj. in Patients With Knee Osteoarthritis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update investigating safety and potential efficacy of FURESTEM-OA Kit Inj. in knee osteoarthritis across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FURESTEM-OA Kit Inj.

Snippet

Sponsor: Kang Stem Biotech Co., Ltd. | Conditions: Knee Osteoarthritis | Phase 1, Phase 2 | Status: UNKNOWN